Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04524715

LLLT Treatment of Lung Inflammation in COVID-19

Low-Level Laser Therapy Treatment of Lung Inflammation in COVID-19 Patients

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Ward Photonics LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine if a reduction of pneumonic inflammation occurs after treatment with Low-Level Laser Therapy (LLLT) applying red-light technology in the respiratory system of COVID-19 patients suffering from acute viral pneumonia.

Detailed description

This clinical trial is a blinded before and after comparison of the effect on patients treated with a red-light LLLT therapy for acute lung inflammation as a result of COVID-19 infection. Patients are enrolled to undergo LLLT therapy in addition to all standard ongoing therapies for COVID-19. Outcomes for patients receiving LLLT in addition to their standard care (the treatment group) are compared to the group receiving only standard therapy for COVID-19 (control group). Effects of LLLT treatment are measured immediately following treatment, and outcome measurements are compared to the pre-treatment baseline.

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive red LLLT treatment to chest of patient.Expose patient to LLLT light while lying on their back, elevated at an angle of approximately 45 degrees from horizontal. Position light over the patient's chest at a 33-degree bias to their right and left sides for 20 minutes each side respectively.
DEVICESham Device TreatmentExpose patient to sham device while lying on their back, elevated at an angle of approximately 45 degrees from horizontal. Position light over the patient's chest at a 33-degree bias to their right and left sides for 20 minutes each side respectively.

Timeline

Start date
2021-07-31
Primary completion
2022-03-31
Completion
2022-03-31
First posted
2020-08-24
Last updated
2022-07-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04524715. Inclusion in this directory is not an endorsement.